[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Advitech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advitech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aegerion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aegerion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aeolus Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aeolus Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aes Chemunex Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aes Chemunex Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Afexa Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Afexa Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Affitech AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affitech AS Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Affymax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affymax, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Affymetrix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affymetrix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Agenix Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agenix Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Agennix AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agennix AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AGI Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AGI Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Agilent Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agilent Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ahlcon Parenterals (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ahlcon Parenterals (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ahn-Gook Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ahn-Gook Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AiDA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AiDA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ajanta Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ajanta Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Akela Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Akela Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aker BioMarine ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aker BioMarine ASA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Akorn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Akorn Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alapis S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alapis S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Albany Molecular Research Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Albany Molecular Research Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Albert David Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Albert David Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alchemia Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alchemia Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 78 pages

Alembic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alembic Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alexandria Pharmaceuticals & Chemical Industries Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexandria Pharmaceuticals & Chemical Industries Co. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alexion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alexza Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexza Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Algeta ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Algeta ASA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alkermes, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alkermes, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Allergan Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allergan Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Allergy Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allergy Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alliance Pharma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alliance Pharma plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alliance Pharmaceutical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alliance Pharmaceutical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Allied Biotech Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allied Biotech Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Allon Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allon Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Allos Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allos Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alnylam Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alnylam Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alpa Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alpa Laboratories Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AlphaHelix Molecular Diagnostics AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AlphaHelix Molecular Diagnostics AB Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alseres Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alseres Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AlumiFuel Power Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AlumiFuel Power Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AMAG Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AMAG Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amarillo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amarillo Biosciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 57 pages

Amarin Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amarin Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amazon Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amazon Biotech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ambalal Sarabhai Enterprises Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ambalal Sarabhai Enterprises Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

American Biogenetic Sciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

American Biogenetic Sciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amgen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amgen, Inc., a biotechnology company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. Products The company markets primarily recombinant protein therapeutics in...

April 2024 78 pages

Amicus Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amicus Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ProMIS Neurosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProMIS Neurosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers